Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Abstral
Fentanyl citrate 157.1mcg equivalent to fentanyl 100mcg
Sublingual tablet
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Aesica Queenborough Limited, Queenborough, United Kingdom
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Abstral
Fentanyl citrate 314.2mcg equivalent to fentanyl 200mcg
Sublingual tablet
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Aesica Queenborough Limited, Queenborough, United Kingdom
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Abstral
Fentanyl citrate 471.3mcg equivalent to fentanyl 300mcg
Sublingual tablet
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Aesica Queenborough Limited, Queenborough, United Kingdom
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Abstral
Fentanyl citrate 628.4mcg equivalent to fentanyl 400mcg
Sublingual tablet
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Aesica Queenborough Limited, Queenborough, United Kingdom
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Abstral
Fentanyl citrate 942.6mcg equivalent to fentanyl 600mcg
Sublingual tablet
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Aesica Queenborough Limited, Queenborough, United Kingdom
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Abstral
Fentanyl citrate 1257mcg equivalent to fentanyl 800mcg
Sublingual tablet
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Aesica Queenborough Limited, Queenborough, United Kingdom
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Tagrisso
Osimertinib mesilate 47.7mg equivalent to osimertinib 40mg
Film coated tablet
AstraZeneca Limited
AstraZeneca AB, Sodertalje, Sweden
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Tagrisso
Osimertinib mesilate 95.4mg equivalent to osimertinib 80mg
Film coated tablet
AstraZeneca Limited
AstraZeneca AB, Sodertalje, Sweden
|
Dated this 29th day of September 2017.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on the 11th day of September 2013).
Gazette.govt.nz